New Releases from NCBI BookshelfDasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal).Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal).
Post Content
